Lead Sponsor

Transcend Therapeutics

Age

All ages

Sex

ALL

Healthy Volunteers

No

•Completion of a double-blind Transcend-sponsored clinical trial with TSND-201 (e.g., TSND201-PTSD-301) and considered in good standing with the study site.
•Proficient in communication (verbal and reading) to complete interviews and written questionnaires.
•Agree to not participate in any other interventional clinical trials for the duration of this study.

•Experienced an intolerable side effect following dosing with TSND-201 in the prior study.
•Had significant deviation(s)/non-compliance in parent study in the opinion of the Investigator which would deem them unsuitable for participation.
•Change or development of any physical or psychological finding that would make participant unsuitable for study.